Deep learning to detect left ventricular structural abnormalities in chest X-rays

Shreyas Bhave,Victor Rodriguez,Timothy Poterucha,Simukayi Mutasa,Dwight Aberle,Kathleen M Capaccione,Yibo Chen,Belinda Dsouza,Shifali Dumeer,Jonathan Goldstein,Aaron Hodes,Jay Leb,Matthew Lungren,Mitchell Miller,David Monoky,Benjamin Navot,Kapil Wattamwar,Anoop Wattamwar,Kevin Clerkin,David Ouyang,Euan Ashley,Veli K Topkara,Mathew Maurer,Andrew J Einstein,Nir Uriel,Shunichi Homma,Allan Schwartz,Diego Jaramillo,Adler J Perotte,Pierre Elias
DOI: https://doi.org/10.1093/eurheartj/ehad782
IF: 39.3
2024-03-20
European Heart Journal
Abstract:Abstract Background and Aims Early identification of cardiac structural abnormalities indicative of heart failure is crucial to improving patient outcomes. Chest X-rays (CXRs) are routinely conducted on a broad population of patients, presenting an opportunity to build scalable screening tools for structural abnormalities indicative of Stage B or worse heart failure with deep learning methods. In this study, a model was developed to identify severe left ventricular hypertrophy (SLVH) and dilated left ventricle (DLV) using CXRs. Methods A total of 71 589 unique CXRs from 24 689 different patients completed within 1 year of echocardiograms were identified. Labels for SLVH, DLV, and a composite label indicating the presence of either were extracted from echocardiograms. A deep learning model was developed and evaluated using area under the receiver operating characteristic curve (AUROC). Performance was additionally validated on 8003 CXRs from an external site and compared against visual assessment by 15 board-certified radiologists. Results The model yielded an AUROC of 0.79 (0.76–0.81) for SLVH, 0.80 (0.77–0.84) for DLV, and 0.80 (0.78–0.83) for the composite label, with similar performance on an external data set. The model outperformed all 15 individual radiologists for predicting the composite label and achieved a sensitivity of 71% vs. 66% against the consensus vote across all radiologists at a fixed specificity of 73%. Conclusions Deep learning analysis of CXRs can accurately detect the presence of certain structural abnormalities and may be useful in early identification of patients with LV hypertrophy and dilation. As a resource to promote further innovation, 71 589 CXRs with adjoining echocardiographic labels have been made publicly available.
cardiac & cardiovascular systems
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the early identification of cardiac structural abnormalities in chest X - ray (CXR) images, especially septal left ventricular hypertrophy (SLVH) and dilated left ventricle (DLV), which are important indicators of heart failure. By using deep - learning methods to analyze CXR images, the research aims to develop a model that can accurately detect these cardiac structural abnormalities, so as to promote the early diagnosis of heart failure and improve patient prognosis. Although traditional diagnostic methods such as echocardiography are accurate, they are costly and not suitable for large - scale screening. In contrast, CXR examinations are more common and less costly, so the use of CXR for the detection of cardiac structural abnormalities has important clinical significance and social value. The specific objectives of the paper include: - Developing a deep - learning model that can accurately identify SLVH and DLV based on CXR images. - Evaluating the performance of this model on different hospital datasets to ensure its generalization ability. - Comparing the accuracy of the model with the visual assessment results of 15 certified radiologists to verify the effectiveness of the model. - Using saliency mapping techniques to determine which parts of the CXR the model is most sensitive to when making predictions, so as to ensure that the model focuses on cardiac structures rather than other potential confounding factors. By achieving the above - mentioned objectives, the research hopes to provide a new, cost - effective method for the early identification of cardiac structural abnormalities, which will help diagnose heart failure earlier and improve the treatment effect of patients.